Biotage

Biotage EBIT

Delisted

The EBIT of Biotage (BIOT.ST) as of Oct 17, 2026 is 383.00 M SEK. In the previous year, EBIT was 376.00 M SEK — a change of 1.86% (higher).

EBIT

383.00 MSEK

YoY

1.86%

Last updated:

In 2024, Biotage's EBIT was 383.00 M SEK, a 1.86% increase from the 376.00 M SEK EBIT recorded in the previous year.

The Biotage EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2022
330.00 M SEK
Jan 1, 2023
376.00 M SEK
Jan 1, 2024
383.00 M SEK
Jan 1, 2025 (e)
383.35 M SEK
Jan 1, 2026 (e)
414.73 M SEK
Jan 1, 2027 (e)
452.32 M SEK
Jan 1, 2028 (e)
708.26 M SEK
Jan 1, 2031 (e)
0.00 SEK
The Biotage EBIT history
YEAREBITYoY
est0.00SEK-100.00%
est708.26 MSEK+56.58%
est452.32 MSEK+9.06%
est414.73 MSEK+8.19%
est383.35 MSEK+0.09%
383.00 MSEK+1.86%
376.00 MSEK+13.94%
330.00 MSEK+21.77%
271.00 MSEK+29.22%
209.72 MSEK-0.27%
210.29 MSEK+21.15%
173.59 MSEK+29.90%
133.63 MSEK+34.82%
99.11 MSEK+32.53%
74.79 MSEK+51.66%
49.31 MSEK+25.81%
39.20 MSEK-10.61%
43.85 MSEK+74.86%
25.08 MSEK-105.99%
-418.76 MSEK+4,036.72%
-10.12 MSEK-145.00%
22.50 MSEK-47.59%
42.92 MSEK+564.13%
6.46 MSEK-110.27%
-62.95 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biotage Revenue

Biotage Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
1.57 B SEK
330.00 M SEK
268.00 M SEK
Jan 1, 2023
1.86 B SEK
376.00 M SEK
246.00 M SEK
Jan 1, 2024
2.06 B SEK
383.00 M SEK
284.00 M SEK
Jan 1, 2025 (e)
1.91 B SEK
383.35 M SEK
270.34 M SEK
Jan 1, 2026 (e)
2.07 B SEK
414.73 M SEK
340.82 M SEK
Jan 1, 2027 (e)
2.26 B SEK
452.32 M SEK
387.28 M SEK
Jan 1, 2028 (e)
3.53 B SEK
708.26 M SEK
600.75 M SEK
Jan 1, 2031 (e)
4.79 B SEK
0.00 SEK
0.00 SEK

Biotage Margins

Biotage stock margins

The Biotage margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Biotage. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Biotage.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
60.54 %
21.07 %
17.11 %
Jan 1, 2023
54.40 %
20.19 %
13.21 %
Jan 1, 2024
62.69 %
18.63 %
13.81 %
Jan 1, 2025 (e)
62.69 %
20.05 %
14.14 %
Jan 1, 2026 (e)
62.69 %
20.05 %
16.48 %
Jan 1, 2027 (e)
62.69 %
20.05 %
17.17 %
Jan 1, 2028 (e)
62.69 %
20.05 %
17.01 %
Jan 1, 2031 (e)
62.69 %
0.00 %
0.00 %

Biotage Stock analysis

What does Biotage do? Biotage AB is a Swedish company founded in 1983. Since then, the company has become an international leader in the development, manufacturing, and marketing of equipment, chemicals, and accessories for organic and medicinal chemistry, pharmacy, biochemistry, and food analysis. The company's business model is based on the development and marketing of innovative instruments and technologies for analytics and chromatography. Consumables and accessory products are also an important part of the business model. Biotage offers customized solutions tailored to each customer's specific needs. Biotage systems are widely used in the pharmaceutical, biotech, and academic sectors. The company is divided into four main divisions: chromatography, spectroscopy, analytics, and synthesis. In the chromatography division, Biotage offers a wide range of systems for sample preparation and analysis, including flash chromatography systems, HPLC systems, and automation solutions for column development. In the spectroscopy division, Biotage offers systems for molecular structure determination, including NMR spectrometers and FT-IR spectrometers. In the analytics division, the company specializes in mass spectrometry and offers a wide range of instruments and accessories, including HPLC-MS systems, MALDI-TOF systems, and LC-MS applications. In the synthesis division, the focus is on the development and marketing of tools for the synthesis, purification, and analysis of peptides and synthesis kits. Biotage is also known for its wide range of chemicals and accessory products. The company offers a variety of solvents, catalysts, reagents, and separation columns that can be used in organic, pharmaceutical, and biological synthesis. Accessory products include items such as activated carbon filter cartridges or membranes for various chromatography systems. Despite the wide range of products, Biotage has focused on specialized markets, particularly drug research and development, peptide synthesis, and the production of specialty chemicals. In these markets, the devices and chemicals are used to develop and produce medications and important blockbuster compounds. In conclusion, Biotage is a company that focuses on the development and marketing of instruments and technologies for analytics and chromatography. Thanks to its strong market presence and innovative products, the company has become an internationally recognized manufacturer. Biotage is headquartered in Sweden, but its global network of sales and service centers enables global presence and development. Biotage is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Biotage's EBIT

Biotage's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Biotage's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Biotage's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Biotage’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Biotage stock

EBIT of Biotage is 383.00 M SEK in 2024.

EBIT of Biotage changed from 376.00 M SEK to 383.00 M SEK, representing a 1.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Biotage since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Biotage historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Biotage

All Key Metrics — Biotage